Admissions and credentials

New York

Experience

Aescape Acquires Exclusive Rights to Tom Brady’s Science-Backed Longevity Protocols

September 23, 2025

Cooley advised Aescape, the leader in artificial intelligence-powered recovery technology, on its acquisition of the exclusive rights to Tom Brady’s recovery and longevity protocols.

Read more

Related contacts

Mike Lincoln
Vice Chair, Reston
Danielle Gershowitz
Partner, New York
Alex Abelson
Associate, New York
Adam Chase
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Rhea George
Associate, New York
Stephanie Gentile
Partner, New York
Joshua Holleman
Partner, Washington, DC
Wesley Dietrich
Associate, Washington, DC
Caolinn Mejza
Associate, New York
Talya Whyte
Associate, New York

Related Practices & Industries

Brigit Announces up to $460 Million Sale to Upbound Group

December 12, 2024

Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.

Read more

Related contacts

Stephane Levy
Partner, New York
David Silverman
Partner, New York
Nathan Baum
Special Counsel, New York
Stephanie Gentile
Partner, New York
Obrea Poindexter
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Megan Browdie
Partner, Washington, DC
Len Jacoby
Partner, New York
Sarah Buchik
Associate, New York
Cara Buchicchio
Associate, New York
Sharon Davidov
Associate, New York
Rhea George
Associate, New York
Ryan Guo
Associate, New York
Norris Kadet
Associate, New York
Bomin Kim
Associate, New York
Nicollette R. Kirby
Associate, Washington, DC
Dana N. Levin
Associate, New York
Joseph Lockinger
Special Counsel, New York
Well Mackey Jr
Associate, New York
Scott D. Rudin
Associate, New York
Hardy Zhou
Associate, New York
John Paul Oleksiuk
Partner, New York
Bryan Berman
Special Counsel, Colorado
Calvin Lee
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Photon Health Closes $9 Million Financing Round

August 15, 2024

Cooley advised Photon Health, a digital health platform designed to help patients manage their prescriptions, on its $9 million financing round. Notation and Flare Capital Partners led the round. Roy Moran, Alex Abelson, Steve Andersen and Rhea George led the Cooley team advising Photon.

Related contacts

Roy Moran
Partner, New York
Alex Abelson
Associate, New York
Steve Andersen
Associate, New York
Rhea George
Associate, New York

Related Practices & Industries

Graviton Bioscience Closes Strategic Investment from Sanofi

February 2, 2024

Cooley advised Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 and other therapeutic compounds, on its strategic investment from Sanofi. Partners Brandon Fenn and Alan Tamarelli led the Cooley team advising Graviton Bioscience.

Related contacts

Brandon W. Fenn
Partner, New York
Alan W. Tamarelli
Partner, New York
Ken Rollins
Partner in Charge – San Diego, San Diego
Alex Abelson
Associate, New York
Sophie Kraff
Associate, New York
Rhea George
Associate, New York
Christopher Kimball
Partner, Washington, DC

Related Practices & Industries

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.